Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
US11787841B2 · kind B2 · utility
0Cited by
84References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2021 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Jul 3, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to various different types of mutations in the thrA gene in E. coli leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.